| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Peter D. Currie | Q56046863 |
| Joachim Berger | Q57431900 | ||
| P2860 | cites work | Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies | Q22001192 |
| Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy | Q24306218 | ||
| Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy | Q24308817 | ||
| Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan | Q24316123 | ||
| Mutations in the integrin alpha7 gene cause congenital myopathy | Q24317420 | ||
| Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures | Q24318933 | ||
| Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI | Q24629650 | ||
| Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study | Q24643018 | ||
| The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy | Q24681141 | ||
| Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124 | Q27660081 | ||
| Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses | Q28141198 | ||
| Defective membrane repair in dysferlin-deficient muscular dystrophy | Q28203095 | ||
| In vivo imaging of molecular interactions at damaged sarcolemma | Q28261975 | ||
| Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy | Q28281738 | ||
| A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B | Q28281749 | ||
| Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice | Q28590908 | ||
| The ATPase-dependent chaperoning activity of Hsp90a regulates thick filament formation and integration during skeletal muscle myofibrillogenesis | Q28754755 | ||
| Animal models of human disease: zebrafish swim into view | Q29615723 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment | Q30490034 | ||
| The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies | Q30499359 | ||
| The dystrophin associated protein complex in zebrafish | Q31134324 | ||
| Zebrafish orthologs of human muscular dystrophy genes | Q33279472 | ||
| The role of zebrafish in chemical genetics | Q33300427 | ||
| Zebrafish models for human FKRP muscular dystrophies | Q33594227 | ||
| Drug screening in a zebrafish model of Duchenne muscular dystrophy. | Q33845739 | ||
| Zebrafish models of collagen VI-related myopathies | Q33878282 | ||
| PTC124 targets genetic disorders caused by nonsense mutations | Q34003720 | ||
| Very mild muscular dystrophy associated with the deletion of 46% of dystrophin | Q34371637 | ||
| Dystrophin in adult zebrafish muscle | Q74393273 | ||
| Local dystrophin restoration with antisense oligonucleotide PRO051 | Q80412961 | ||
| The 2012 version of the gene table of monogenic neuromuscular disorders | Q83257090 | ||
| The struggle to model muscular dystrophy | Q84327051 | ||
| Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies | Q34766986 | ||
| A dystroglycan mutation associated with limb-girdle muscular dystrophy. | Q34767085 | ||
| Zebrafish integrin-linked kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion complex | Q34774115 | ||
| Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. | Q34994545 | ||
| Interventions for muscular dystrophy: molecular medicines entering the clinic | Q35014916 | ||
| Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish | Q35216325 | ||
| A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. | Q36232550 | ||
| Forced expression of dystrophin deletion constructs reveals structure-function correlations. | Q36237129 | ||
| Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome | Q37098005 | ||
| Genetic isolation and characterization of a splicing mutant of zebrafish dystrophin | Q37102146 | ||
| Dystroglycanopathies: coming into focus | Q37852376 | ||
| Exercise and Duchenne muscular dystrophy: toward evidence-based exercise prescription. | Q37853099 | ||
| Targeting RNA to treat neuromuscular disease | Q37909000 | ||
| Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP). | Q38291016 | ||
| Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells | Q38299785 | ||
| Different localization of dystrophin in developing and adult human skeletal muscle | Q41985725 | ||
| Characterization of zebrafish dysferlin by morpholino knockdown. | Q42255405 | ||
| Targeted gene disruption in somatic zebrafish cells using engineered TALENs | Q42862072 | ||
| Protein O-mannosylation is necessary for normal embryonic development in zebrafish | Q43064260 | ||
| Mitochondrial dysfunction and apoptosis in myopathic mice with collagen VI deficiency. | Q44661085 | ||
| Expression of Deletion-Containing Dystrophins in mdx Muscle: Implications for Gene Therapy and Dystrophin Function | Q45868162 | ||
| Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. | Q46823860 | ||
| Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo | Q47073103 | ||
| Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. | Q47073130 | ||
| Genes controlling and mediating locomotion behavior of the zebrafish embryo and larva. | Q47073234 | ||
| The UCS factor Steif/Unc-45b interacts with the heat shock protein Hsp90a during myofibrillogenesis | Q47073713 | ||
| Dystrophin-deficient zebrafish feature aspects of the Duchenne muscular dystrophy pathology | Q47073756 | ||
| The myosin co-chaperone UNC-45 is required for skeletal and cardiac muscle function in zebrafish | Q47073763 | ||
| Delta-sarcoglycan is necessary for early heart and muscle development in zebrafish | Q47073817 | ||
| Quantification of birefringence readily measures the level of muscle damage in zebrafish. | Q47073970 | ||
| Delta-sarcoglycan is required for early zebrafish muscle organization | Q47074188 | ||
| Conserved synteny and the zebrafish genome | Q48055824 | ||
| Collagen VI deficiency induces early onset myopathy in the mouse: an animal model for Bethlem myopathy. | Q52532612 | ||
| Characterisation of dystrophin during development of human skeletal muscle | Q68134305 | ||
| P433 | issue | 6 | |
| P921 | main subject | eukaryote | Q19088 |
| tissue | Q40397 | ||
| Danio rerio | Q169444 | ||
| human musculoskeletal system | Q726543 | ||
| animal disease model | Q64732998 | ||
| biomedical investigative technique | Q66648976 | ||
| P304 | page(s) | 726-732 | |
| P577 | publication date | 2012-11-01 | |
| P1433 | published in | Disease Models & Mechanisms | Q1524006 |
| P1476 | title | Zebrafish models flex their muscles to shed light on muscular dystrophies | |
| P478 | volume | 5 |
| Q45364883 | 503unc, a small and muscle-specific zebrafish promoter |
| Q59134959 | A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies |
| Q28084979 | Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy |
| Q38399671 | Calsequestrins in skeletal and cardiac muscle from adult Danio rerio |
| Q36305781 | Computational approaches for understanding the diagnosis and treatment of Parkinson's disease |
| Q37610505 | Current Translational Research and Murine Models For Duchenne Muscular Dystrophy. |
| Q47704855 | Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification. |
| Q89448668 | Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine |
| Q54221386 | Endotoxin molecule lipopolysaccharide-induced zebrafish inflammation model: a novel screening method for anti-inflammatory drugs. |
| Q38785603 | Establishment and Characterization of a New Muscle Cell Line of Zebrafish (Danio rerio) as an In Vitro Model for Gene Expression Studies |
| Q52506936 | Facioscapulohumeral Muscular Dystrophy. |
| Q90147730 | Failure to identify modifiers of NEBULIN-related nemaline myopathy in two pre-clinical models of the disease |
| Q38603658 | Gene therapy in monogenic congenital myopathies |
| Q30443094 | Impaired embryonic motility in dusp27 mutants reveals a developmental defect in myofibril structure |
| Q34637394 | Loss of Tropomodulin4 in the zebrafish mutant träge causes cytoplasmic rod formation and muscle weakness reminiscent of nemaline myopathy |
| Q56814708 | Model organism data evolving in support of translational medicine |
| Q26991681 | Model organisms in the fight against muscular dystrophy: lessons from drosophila and Zebrafish |
| Q22065593 | Nonhuman genetics. Genomic basis for the convergent evolution of electric organs |
| Q30370360 | Recent advances in the study of zebrafish extracellular matrix proteins. |
| Q28551915 | Recent advances using zebrafish animal models for muscle disease drug discovery |
| Q34351088 | Robotic injection of zebrafish embryos for high-throughput screening in disease models. |
| Q37529679 | Skeletal muscle fiber type: using insights from muscle developmental biology to dissect targets for susceptibility and resistance to muscle disease |
| Q27028125 | Swimming into prominence: the zebrafish as a valuable tool for studying human myopathies and muscular dystrophies. |
| Q35228265 | Swimming-induced exercise promotes hypertrophy and vascularization of fast skeletal muscle fibres and activation of myogenic and angiogenic transcriptional programs in adult zebrafish |
| Q40975689 | Tmem2 regulates cell-matrix interactions that are essential for muscle fiber attachment |
| Q49642318 | Zebrafish Embryonic Slow Muscle Is a Rapid System for Genetic Analysis of Sarcomere Organization by CRISPR/Cas9, but Not NgAgo |
| Q34389847 | Zebrafish as a model system to study toxicology |
| Q53477530 | [Potential of the zebrafish model to study congenital muscular dystrophies]. |
Search more.